NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC • US6373722023

13.44 USD
+0.51 (+3.94%)
At close: Feb 26, 2026
13.44 USD
0 (0%)
After Hours: 2/26/2026, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, NRC scores 5 out of 10 in our fundamental rating. NRC was compared to 101 industry peers in the Health Care Providers & Services industry. NRC has an excellent profitability rating, but there are concerns on its financial health. NRC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NRC was profitable.
  • NRC had a positive operating cash flow in the past year.
  • NRC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years NRC had a positive operating cash flow.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • NRC's Return On Assets of 8.60% is amongst the best of the industry. NRC outperforms 92.08% of its industry peers.
  • NRC has a Return On Equity of 82.92%. This is amongst the best in the industry. NRC outperforms 97.03% of its industry peers.
  • NRC has a Return On Invested Capital of 16.19%. This is amongst the best in the industry. NRC outperforms 93.07% of its industry peers.
  • NRC had an Average Return On Invested Capital over the past 3 years of 24.89%. This is significantly above the industry average of 8.95%.
  • The last Return On Invested Capital (16.19%) for NRC is well below the 3 year average (24.89%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROIC 16.19%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

1.3 Margins

  • The Profit Margin of NRC (8.44%) is better than 90.10% of its industry peers.
  • NRC's Profit Margin has declined in the last couple of years.
  • NRC has a Operating Margin of 16.44%. This is amongst the best in the industry. NRC outperforms 95.05% of its industry peers.
  • NRC's Operating Margin has declined in the last couple of years.
  • NRC has a Gross Margin of 61.88%. This is amongst the best in the industry. NRC outperforms 82.18% of its industry peers.
  • NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.
  • The number of shares outstanding for NRC has been reduced compared to 1 year ago.
  • Compared to 5 years ago, NRC has less shares outstanding
  • Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • NRC has an Altman-Z score of 2.70. This is not the best score and indicates that NRC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.70, NRC is in line with its industry, outperforming 59.41% of the companies in the same industry.
  • NRC has a debt to FCF ratio of 5.02. This is a neutral value as NRC would need 5.02 years to pay back of all of its debts.
  • The Debt to FCF ratio of NRC (5.02) is better than 62.38% of its industry peers.
  • NRC has a Debt/Equity ratio of 5.36. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 5.36, NRC is doing worse than 78.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Altman-Z 2.7
ROIC/WACC2.06
WACC7.85%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • NRC has a Current Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.55, NRC is not doing good in the industry: 86.14% of the companies in the same industry are doing better.
  • NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of NRC (0.55) is worse than 83.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1

3. Growth

3.1 Past

  • The earnings per share for NRC have decreased strongly by -50.56% in the last year.
  • The Earnings Per Share has been growing slightly by 3.24% on average over the past years.
  • Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.96% in the last year.
  • NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.75, the valuation of NRC can be described as very reasonable.
  • NRC's Price/Earnings ratio is rather cheap when compared to the industry. NRC is cheaper than 91.09% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.21. NRC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.75
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 68.32% of the companies listed in the same industry.
  • 67.33% of the companies in the same industry are more expensive than NRC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.33
EV/EBITDA 12.17
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.32
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • NRC has a Yearly Dividend Yield of 5.14%, which is a nice return.
  • The stock price of NRC dropped by -20.89% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 0.49, NRC pays a better dividend. On top of this NRC pays more dividend than 99.01% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.14%

5.2 History

  • The dividend of NRC has a limited annual growth rate of 2.80%.
  • NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.8%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • NRC pays out 94.64% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of NRC is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP94.64%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (2/26/2026, 8:00:02 PM)

After market: 13.44 0 (0%)

13.44

+0.51 (+3.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners49.6%
Inst Owner Change-2.75%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap304.28M
Revenue(TTM)137.39M
Net Income(TTM)11.60M
Analysts45
Price TargetN/A
Short Float %3.05%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 5.14%
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP94.64%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.75
Fwd PE N/A
P/S 2.21
P/FCF 19.33
P/OCF 11.5
P/B 21.75
P/tB N/A
EV/EBITDA 12.17
EPS(TTM)1.25
EY9.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.17%
OCF(TTM)1.17
OCFY8.69%
SpS6.07
BVpS0.62
TBVpS-2.3
PEG (NY)N/A
PEG (5Y)3.32
Graham Number4.17
Profitability
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROCE 22.99%
ROIC 16.19%
ROICexc 16.9%
ROICexgc 56.88%
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
FCFM 11.46%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.43%
ROICexc(5y)39.02%
ROICexgc(3y)111.05%
ROICexgc(5y)N/A
ROCE(3y)35.35%
ROCE(5y)42.3%
ROICexgc growth 3Y-50.84%
ROICexgc growth 5Y-30.78%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.55%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Debt/EBITDA 2.48
Cap/Depr 140.43%
Cap/Sales 7.79%
Interest Coverage 250
Cash Conversion 87.54%
Profit Quality 135.72%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 2.7
F-Score6
WACC7.85%
ROIC/WACC2.06
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)95.08%
Profit Quality(5y)95.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.69%
EBIT growth 3Y-27.99%
EBIT growth 5Y-11.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NRC.


Can you provide the valuation status for NATIONAL RESEARCH CORP?

ChartMill assigns a valuation rating of 5 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?

The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 10.75 and the Price/Book (PB) ratio is 21.75.


Can you provide the financial health for NRC stock?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.